Business Context and Reporting Period
Company: Chemical & Mining Co of Chile Inc (SQM)
Filing Type: Form 6-K (Earnings Release)
Reporting Period: Nine months ended September 30, 2025 (9M2025) and Third Quarter 2025 (3Q2025)
Business Overview: SQM is a global producer of lithium, iodine, and specialty plant nutrition products. The company operates primarily in Chile (Salar de Atacama) and Australia (Mt. Holland).
Key Financial Metrics
| Metric (US$ Millions) | 9M 2025 | 9M 2024 | 3Q 2025 | 3Q 2024 |
|---|---|---|---|---|
| Total Revenues | 3,252.4 | 3,455.0 | 1,173.0 | 1,076.9 |
| Gross Profit | 904.1 | 1,033.3 | 345.8 | 280.8 |
| Gross Margin | 27.8% | 29.9% | 29.5% | 26.1% |
| Net Income | 404.4 | (524.5) | 178.4 | 131.4 |
| EPS (US$) | 1.42 | (1.84) | 0.62 | 0.46 |
| Adjusted EBITDA | 1,071.6 | 1,155.5 | 404.1 | 327.3 |
| Adjusted EBITDA Margin | 32.9% | 33.4% | 34.5% | 30.4% |
| Cash & Equivalents | 1,491.2 | 1,565.4 | - | - |
| Total Debt (Short + Long) | 4,649.5 | 4,809.4 | - | - |
| Liquidity Ratio | 2.8 | 2.9 | - | - |
Material Changes vs. Prior Period
- Profitability Turnaround: The company reported a net income of US$404.4 million for 9M2025, a significant improvement from a net loss of US$524.5 million in the same period of 2024. This reversal was driven by lower income tax expenses (US$216.6 million vs. US$1,301.1 million) and improved operating performance.
- Revenue Decline: Total revenues decreased 5.9% year-over-year to US$3,252.4 million, primarily due to a 43% drop in Potassium revenues and a 9.2% decline in Lithium revenues for the nine-month period.
- Quarterly Growth: In contrast to the nine-month trend, 3Q2025 revenues increased 8.9% year-over-year to US$1,173.0 million, with Lithium revenues up 21.4%.
- Segment Performance:
- Lithium: Achieved record sales volumes (181.0 thousand MT for 9M2025). Realized average prices in Chile increased 3.5% quarter-over-quarter to ~US$8.8/kg.
- Potassium: Revenues fell 43% as the company strategically reduced production to prioritize lithium and lower brine extraction.
- Iodine: Revenues increased 3.8% for 9M2025, supported by strong pricing (US$72.7/kg).
- Specialty Plant Nutrition: Revenues grew 2.1% for 9M2025 due to a shift toward high-value specialty blends.
Guidance, Outlook, and Management Commentary
- Lithium Outlook: Management expects the upward price trend to continue into Q4 2025, supported by demand from electric vehicles (EVs) and energy storage systems (ESS), which now represent over 20% of global lithium demand.
- Capital Expenditure (Capex): Updated total capex estimate for 2025–2027 is US$2.7 billion, evenly distributed over the three years. Approximately 25% is allocated to maintenance. Key projects include the seawater pipeline, Maria Elena iodine site, and expansions in Chile and Australia.
- Strategic Milestones:
- Received authorization from the Chinese antitrust authority (SAMR) for the joint venture with Codelco to develop the Atacama salt flat.
- Seawater pipeline construction is >80% complete, expected operational in Q2/Q3 2026.
- Australian operations (Mt. Holland) are ramping up smoothly, with record spodumene sales and the start of lithium hydroxide production.
- Risks: Forward-looking statements are subject to risks including market volatility, implementation of the Sustainable Development Plan, and regulatory approvals for joint ventures.
Key Facts for Investor Verification
- Price Trend Reversal: Verify the sustainability of the lithium price increase (first rise in two years) and the impact of inventory destocking in the supply chain.
- Codelco Joint Venture: Monitor the progress of the partnership with Codelco following the SAMR approval and its impact on future production capacity.
- Capex Execution: Track the US$2.7 billion capex plan, specifically the timeline for the seawater pipeline and Australian project ramp-ups.
- Potassium Strategy: Confirm the long-term impact of the strategic reduction in potassium chloride production on overall revenue mix and brine management.
- Tax Expense Volatility: Note the significant decrease in income tax expense (from US$1.3B to US$216.6M) and verify the drivers behind this change for future forecasting.